Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kidney Transplant Infection”

344 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 344 results

Post-approval studies (Phase 4)UnknownNCT03359746
What this trial is testing

Grazoprevir/Elbasvir for Treatment of Hepatitis C Virus Genotype 4 Post Kidney Transplant

Who this might be right for
Hepatitis C
King Faisal Specialist Hospital & Research Center 40
Not applicableStudy completedNCT00134342
What this trial is testing

Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised Populations

Who this might be right for
Tuberculosis
University Health Network, Toronto 203
Not applicableUnknownNCT04694573
What this trial is testing

Multicenter CTS Pre-and Post-Transplantation Covid-19 Serum Studies

Who this might be right for
Covid19Kidney Transplant; ComplicationsKidney Transplant Failure and Rejection+2 more
Heidelberg University 600
Testing effectiveness (Phase 2)Study completedNCT01136395
What this trial is testing

Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation

Who this might be right for
Kidney TransplantationRituximab (RTx)Living Donors+2 more
University of Giessen 85
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT04294472
What this trial is testing

A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients

Who this might be right for
BK Virus Infection
Vera Therapeutics, Inc. 30
Not applicableStudy completedNCT01558037
What this trial is testing

Cell Mediated Immunity With Risk of Cytomegalovirus (CMV) in Solid Organ Transplant Recipients

Who this might be right for
Awaiting Organ TransplantInfection in Solid Organ Transplant Recipients
Michael Ison 113
Not applicableUnknownNCT05483725
What this trial is testing

Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.

Who this might be right for
Kidney DiseasesKidney Transplant; ComplicationsCOVID-19+3 more
Institute for Clinical and Experimental Medicine 108
Not applicableStudy completedNCT01840891
What this trial is testing

Secondary Lactose Intolerance Due to Chronic Norovirus Infection

Who this might be right for
Chronic Diarrhea
University of Zurich 15
Not applicableActive Not RecruitingNCT05708534
What this trial is testing

Evolution of CMV Antiviral T-cell Immunity Over the Next Six Months Initiation of Treatment With Belatacept.

Who this might be right for
Kidney Transplant Infection
University Hospital, Rouen 28
Early research (Phase 1)Ended earlyNCT02922816
What this trial is testing

FMT for MDRO Colonization After Infection in Renal Transplant Recipients

Who this might be right for
Infection Due to Resistant Organism
Emory University 11
Post-approval studies (Phase 4)Study completedNCT03627299
What this trial is testing

Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors

Who this might be right for
End Stage Renal DiseaseHepatitis C
Johns Hopkins University 11
Post-approval studies (Phase 4)Study completedNCT01789203
What this trial is testing

Ciprofloxacin for Prevention of BK Infection

Who this might be right for
BK Virus Infection
The Methodist Hospital Research Institute 200
Testing effectiveness (Phase 2)Study completedNCT03339661
What this trial is testing

Secondary Prophylaxis After CMV Disease in Kidney Transplant Patients Targeted by γδ T Cells Immunomonitoring.

Who this might be right for
Kidney Transplant Infection
University Hospital, Bordeaux 38
Not applicableNot Yet RecruitingNCT07651137
What this trial is testing

Impact of Culture of Perfusion Fluid on Donor-derived Infection Management and Outcome in Liver and Kidney Transplant

Who this might be right for
Liver Transplant InfectionKidney Transplant InfectionLiver Transplant+3 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,400
Not applicableStudy completedNCT03083756
What this trial is testing

Validation of a Risk Score Opportunistic Infections Development in Kidney Transplant Patients

Who this might be right for
Opportunistic Infections
Sociedad Española de Trasplante 577
Large-scale testing (Phase 3)Study completedNCT03123627
What this trial is testing

Randomized Clinical Trial, Open, Multicenter Parallel, no Suspension Inferiority Prophylactic Treatment With Valganciclovir in Kidney Transplant CMV-seropositive Cellular Immunity to Develop CD8 + CMV-specific Treatment After Induction Thymoglobulin.

Who this might be right for
Kidney Transplant Infection
Maimónides Biomedical Research Institute of Córdoba 150
Post-approval studies (Phase 4)Study completedNCT04575896
What this trial is testing

Kidney Transplants in Hepatitis C Negative Recipients With Hepatitis C Viremic Donors

Who this might be right for
End Stage Renal DiseaseHepatitis C
Johns Hopkins University 10
Testing effectiveness (Phase 2)Study completedNCT03110133
What this trial is testing

Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff

Who this might be right for
Clostridium Difficile Infection Recurrence
Finch Research and Development LLC. 206
Next Page